Long-Term Safety, Tolerability, And Efficacy of Efgartigimod in Patients with Generalized Myasthenia Gravis: Concluding Analyses from the ADAPT+ Study

Authors
Category Primary study
JournalNeurology
Year 2023
This article has no abstract
Epistemonikos ID: 04fa332a4abf07bb47a18627d613e2e9a9b6034a
First added on: Nov 03, 2023